DONGGUK UNIVERSITY GYEONGJU CAMPUS INDUSTRY-ACADEMY COOPERATION FOUNDATION
发明人:
SHIN HEUNG MOOK,신흥묵,YANG IN JUN,양인준,LEE KYOO WON,이규원,GUM SANG IL,금상일,PARK YOUNG IL,박영일
申请号：
KR1020170142624
公开号：
KR1019328620000B1
申请日:
2017.10.30
申请国别(地区):
KR
年份:
2018
代理人:
摘要：
An object of the present invention is to provide a pharmaceutical composition for preventing and treating a dry eye syndrome having gallotannin and friedelin. The gallotannin and friedelin contained in the pharmaceutical composition for preventing and treating the dry eye syndrome of the present invention exhibit an excellent corneal inflammation-inhibiting effect and a corneal cell wound healing function, so that the same can be used for preventing and treating an inflammatory reaction of the dry eye syndrome and damage of ocular surface epithelium. The present invention relates to the composition for preventing and treating the dry eye syndrome, the composition can be effectively used for improving symptoms such as a congestion, a burning sensation and a wound in the patient with a dry eye with conjunctivitis due to high osmotic pressure of tear and minute eye damage.본 발명은 안구건조증 예방 및 치료용 조성물에 관한 것으로, 상기 조성물은 눈물의 고삼투압으로 인한 충혈 및 안구 각막의 미세한 손상이 동반되는 안구건조증 환자에서, 충혈감과 작열감 및 상처 등의 증상을 개선하는데 효과적 활용될 수 있다.
